Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription Articles published in Radiology Retrieve available abstracts of 50 articles: HTML format

Single Articles

October 2026
1. SAHA A, Bosma JS, Twilt JJ, Ng ABCD, et al
   Artificial Intelligence for Prostate Cancer Detection and Screening on MRI in Global Populations: The SCARLET-1 Study.
   Radiology. 2026;321:e262081.
   PubMed     Abstract available
   
   
   August 2026
2. COELHO TF, Bosma JS, Bozgo V, Noordman CR, et al
   Diagnostically Calibrated AI Image Quality Framework Applied to Prostate Cancer Detection at MRI.
   Radiology. 2026;320:e253360.
   PubMed     Abstract available
   
   
   July 2026
3. ULANER GA, Bassett JC, Reddy R, Thomsen B, et al
   Erratum for: (61)Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of (61)Cu-labeled PET Radiotracers.
   Radiology. 2026;320:e269013.
   PubMed    
   
   
   
4. MCCLURE TD, Wang S, Ballman KV, Diven M, et al
   Combination of Radiation Therapy and Irreversible Electroporation for Intermediate-Risk Prostate Cancer (RTIRE): A Phase 1 Trial.
   Radiology. 2026;320:e250848.
   PubMed     Abstract available
   
   
   
5. NEZAMI N, Unger KR
   When Electrons Cooperate with Photons: Prostate Cancer Loses Its Sanctuary.
   Radiology. 2026;320:e261563.
   PubMed    
   
   
   June 2026
6. DE BIE KCC, Cornud FC, Walser EM, van Riel LAMJG, et al
   One-year Follow-up after US-guided Transperineal Focal Laser Ablation of Localized Prostate Cancer: Worldwide Registry Study.
   Radiology. 2026;319:e251658.
   PubMed     Abstract available
   
   
   
7. ABIODUN-OJO OA, Jani AB, Goyal S, Lawal IO, et al
   (18)F-Fluciclovine or (68)Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial.
   Radiology. 2026;319:e251874.
   PubMed     Abstract available
   
   
   April 2026
8. FUTELA D, Yin Z, Mirak SA, Ryan S, et al
   Characterization of Clinically Significant Prostate Cancer in the Peripheral Zone Using Rapid B(1)-Insensitive MR Fingerprinting.
   Radiology. 2026;319:e252547.
   PubMed     Abstract available
   
   
   
9. MARGOLIS DJA, Gulani V
   A Step Closer to the Promise of Quantitative MRI for Prostate Cancer.
   Radiology. 2026;319:e260545.
   PubMed    
   
   
   
10. GALGANO SJ, Turner EM
    Quantitative Post-(177)Lu-PSMA-617 SPECT/CT Analysis: Evidence for Adaptive Treatment Planning and Prognostication in Prostate Cancer.
    Radiology. 2026;319:e260836.
    PubMed    
    
    
    
11. AYATI N, Papa N, Crumbaker M, Subramaniam S, et al
    (177)Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer.
    Radiology. 2026;319:e252672.
    PubMed     Abstract available
    
    
    March 2026
12. GIGANTI F, Allen C, Dickinson L, Punwani S, et al
    MRI for Active Surveillance in Prostate Cancer: How I Do It.
    Radiology. 2026;318:e242164.
    PubMed     Abstract available
    
    
    
13. GHODSI A, Owens L, Demirci RA, Gafita A, et al
    PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving (177)Lu-PSMA-617.
    Radiology. 2026;318:e250649.
    PubMed     Abstract available
    
    
    December 2025
14. WOO S, Masci B, Rowe SP, Caruso D, et al
    Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET.
    Radiology. 2025;317:e250701.
    PubMed     Abstract available
    
    
    
15. ULANER GA, Bassett JC, Reddy R, Thomsen B, et al
    (61)Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of (61)Cu-labeled PET Radiotracers.
    Radiology. 2025;317:e251151.
    PubMed     Abstract available
    
    
    July 2025
16. SATTIN C, Pizzi C, Summers P, Gaeta A, et al
    Histopathologic Yields and Concordance of In-Bore MRI-targeted Biopsy for Prostate Cancer Diagnosis.
    Radiology. 2025;316:e241710.
    PubMed     Abstract available
    
    
    May 2025
17. METSER U, Zukotynski K, Mak V, Langer D, et al
    Erratum for: Effect of (18)F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
    Radiology. 2025;315:e259010.
    PubMed    
    
    
    April 2025
18. WESTPHALEN AC
    Building the Foundation for AI in Prostate Cancer Imaging.
    Radiology. 2025;315:e243352.
    PubMed    
    
    
    
19. TURKBEY B, Huisman H, Fedorov A, Macura KJ, et al
    Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0.
    Radiology. 2025;315:e240140.
    PubMed     Abstract available
    
    
    March 2025
20. TAKAHASHI T
    Prostate Cancer Screening: Empirical Clinical Practice for 70 Years.
    Radiology. 2025;314:e242184.
    PubMed    
    
    
    
21. LEE YJ, Moon HW, Choi MH, Eun Jung S, et al
    MRI-based Deep Learning Algorithm for Assisting Clinically Significant Prostate Cancer Detection: A Bicenter Prospective Study.
    Radiology. 2025;314:e232788.
    PubMed     Abstract available
    
    
    
22. HARMATH C
    AI in Prostate Cancer Diagnosis with MRI: A Friend Not a Foe.
    Radiology. 2025;314:e250525.
    PubMed    
    
    
    February 2025
23. STEINHELFER L, Jungmann F, Nickel M, Kaissis G, et al
    Automated CT Measurement of Total Kidney Volume for Predicting Renal Function Decline after (177)Lu Prostate-specific Membrane Antigen-I&T Radioligand Therapy.
    Radiology. 2025;314:e240427.
    PubMed     Abstract available
    
    
    January 2025
24. HUANG H, Mo J, Ding Z, Peng X, et al
    Deep Learning to Simulate Contrast-Enhanced MRI for Evaluating Suspected Prostate Cancer.
    Radiology. 2025;314:e240238.
    PubMed     Abstract available
    
    
    December 2024
25. CORNUD F, de Bie K, van Riel L, Lefevre A, et al
    MRI-directed Micro-US-guided Transperineal Focal Laser Ablation for Localized Prostate Cancer: A 1-year Follow-up Study.
    Radiology. 2024;313:e233371.
    PubMed     Abstract available
    
    
    October 2024
26. YANG DD, Lee LK, Tsui JMG, Leeman JE, et al
    AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer.
    Radiology. 2024;313:e240041.
    PubMed     Abstract available
    
    
    September 2024
27. TAKAHASHI T
    Rationale for MRI-guided Focused Ultrasound Focal Therapy for Prostate Cancer.
    Radiology. 2024;312:e240738.
    PubMed    
    
    
    August 2024
28. JOHNSON PM, Chandarana H
    AI-powered Diagnostics: Transforming Prostate Cancer Diagnosis with MRI.
    Radiology. 2024;312:e241009.
    PubMed    
    
    
    
29. CAI JC, Nakai H, Kuanar S, Froemming AT, et al
    Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI.
    Radiology. 2024;312:e232635.
    PubMed     Abstract available
    
    
    
30. CIVELEK AC
    Prostate Cancer: Improved Patient Care in the Age of Advancing Theranostics.
    Radiology. 2024;312:e241564.
    PubMed    
    
    
    
31. OERTHER B, Nedelcu A, Engel H, Schmucker C, et al
    Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis.
    Radiology. 2024;312:e233337.
    PubMed     Abstract available
    
    
    
32. KOHLBRENNER R, Wu X, Nguyen HG, Cooperberg MR, et al
    Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma.
    Radiology. 2024;312:e232544.
    PubMed     Abstract available
    
    
    
33. TAMMISETTI VS, Jacobs MA
    Evidence-based Diagnostic Performance Benchmarks in Prostate MRI: An Unmet Clinical Need.
    Radiology. 2024;312:e241792.
    PubMed    
    
    
    
34. KUO PH, Morris MJ, Hesterman J, Kendi AT, et al
    Quantitative (68)Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following (177)Lu-PSMA-617 (VISION Trial).
    Radiology. 2024;312:e233460.
    PubMed     Abstract available
    
    
    July 2024
35. GHAI S, Klotz L, Pond GR, Kebabdjian M, et al
    Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer.
    Radiology. 2024;312:e231948.
    PubMed     Abstract available
    
    
    
36. SCIALPI M, Martorana E
    Apparent Diffusion Coefficient and Biopsy in Detecting Cribriform and Intraductal Carcinoma Prostate Cancer.
    Radiology. 2024;312:e241043.
    PubMed    
    
    
    June 2024
37. SCHIEDA N, Nisha Y, Hadziomerovic AR, Prabhakar S, et al
    Comparison of Positive Predictive Values of Biparametric MRI and Multiparametric MRI-directed Transrectal US-guided Targeted Prostate Biopsy.
    Radiology. 2024;311:e231383.
    PubMed     Abstract available
    
    
    
38. JEWELL K, Hofman MS, Ong JSL, Levy S, et al
    Erratum for: Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy.
    Radiology. 2024;311:e249017.
    PubMed    
    
    
    May 2024
39. LIN Y, Yilmaz EC, Belue MJ, Harmon SA, et al
    Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.
    Radiology. 2024;311:e230750.
    PubMed     Abstract available
    
    
    
40. PRIVE BM, Israel B, Janssen MJR, van der Leest MMG, et al
    Multiparametric MRI and (18)F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer.
    Radiology. 2024;311:e231879.
    PubMed     Abstract available
    
    
    April 2024
41. JEWELL K, Hofman MS, Ong JSL, Levy S, et al
    Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy.
    Radiology. 2024;311:e231703.
    PubMed     Abstract available
    
    
    March 2024
42. WOODRUM DA
    Less Is More: MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer.
    Radiology. 2024;310:e240258.
    PubMed    
    
    
    
43. GHAI S, Finelli A, Corr K, Lajkosz K, et al
    MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.
    Radiology. 2024;310:e231473.
    PubMed     Abstract available
    
    
    December 2023
44. MURAD V, Glicksman RM, Berlin A, Santiago A, et al
    Association of PSMA PET-derived Parameters and Outcomes of Patients Treated for Oligorecurrent Prostate Cancer.
    Radiology. 2023;309:e231407.
    PubMed     Abstract available
    
    
    
45. ALABOUSI M, Ghai S, Haider MA
    MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer.
    Radiology. 2023;309:e230431.
    PubMed     Abstract available
    
    
    
46. CIVELEK AC
    PSMA PET Parameters for Predicting Outcomes in Patients with Prostate Cancer.
    Radiology. 2023;309:e233023.
    PubMed    
    
    
    November 2023
47. TAKAHASHI T
    Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials.
    Radiology. 2023;309:e231177.
    PubMed    
    
    
    
48. AGUIRRE DA, Cardona Ortegon JD
    Unlocking the Benefits of Multiparametric MRI for Predicting Prostate Cancer Recurrence.
    Radiology. 2023;309:e232819.
    PubMed    
    
    
    
49. LUZZAGO S, Colombo A, Mistretta FA, Alessi S, et al
    Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy.
    Radiology. 2023;309:e223349.
    PubMed     Abstract available
    
    
    September 2023
50. BISCHOFF LM, Peeters JM, Weinhold L, Krausewitz P, et al
    Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI.
    Radiology. 2023;308:e230427.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum